Clinical Trials
3 trialsNCT04049747 2025-03-24
IP4-CHRONOS
Imperial College London
Phase NA Completed
NCT04239599 2022-09-29
RCT-PHART2
Sunnybrook Health Sciences Centre
Phase NA Unknown
NCT00064610 2008-02-11
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer
Millennium Pharmaceuticals, Inc.
Phase 1/2 Completed